Barry Cusack

773 total citations
12 papers, 545 citations indexed

About

Barry Cusack is a scholar working on Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Barry Cusack has authored 12 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Oncology. Recurrent topics in Barry Cusack's work include Pharmaceutical studies and practices (3 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers) and Pharmacology and Obesity Treatment (2 papers). Barry Cusack is often cited by papers focused on Pharmaceutical studies and practices (3 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers) and Pharmacology and Obesity Treatment (2 papers). Barry Cusack collaborates with scholars based in United States, Ireland and United Kingdom. Barry Cusack's co-authors include Irene Maeve Rea, Tanyalak Parimon, Jacques Noël, J. N. Lavan, K O'Malley, John G. Kelly, John Horgan, J.G. Kelly, Teri Peterson and Sandra G. Jue and has published in prestigious journals such as Cancer Research, Clinical Pharmacology & Therapeutics and British Journal of Clinical Pharmacology.

In The Last Decade

Barry Cusack

9 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry Cusack United States 7 154 123 97 92 85 12 545
Paul A.F. Jansen Netherlands 17 171 1.1× 85 0.7× 51 0.5× 87 0.9× 135 1.6× 25 589
Linda R. Tulner Netherlands 14 191 1.2× 133 1.1× 82 0.8× 51 0.6× 103 1.2× 24 592
Dean G. Haxby United States 14 130 0.8× 58 0.5× 166 1.7× 102 1.1× 139 1.6× 29 769
J. N. Lavan Ireland 12 101 0.7× 107 0.9× 60 0.6× 94 1.0× 145 1.7× 19 1.3k
Henk Buurma Netherlands 16 409 2.7× 75 0.6× 66 0.7× 144 1.6× 135 1.6× 30 727
F. Nicklason Australia 14 260 1.7× 100 0.8× 38 0.4× 93 1.0× 67 0.8× 20 685
Jos P.C.M. van Campen Netherlands 17 292 1.9× 139 1.1× 67 0.7× 54 0.6× 168 2.0× 30 832
Patrice Queneau France 12 171 1.1× 106 0.9× 69 0.7× 93 1.0× 23 0.3× 80 633
Karl‐Günter Gaßmann Germany 17 303 2.0× 113 0.9× 175 1.8× 65 0.7× 130 1.5× 31 847
Cecilia Della Vedova Italy 9 350 2.3× 91 0.7× 65 0.7× 132 1.4× 44 0.5× 10 616

Countries citing papers authored by Barry Cusack

Since Specialization
Citations

This map shows the geographic impact of Barry Cusack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Cusack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Cusack more than expected).

Fields of papers citing papers by Barry Cusack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Cusack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Cusack. The network helps show where Barry Cusack may publish in the future.

Co-authorship network of co-authors of Barry Cusack

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Cusack. A scholar is included among the top collaborators of Barry Cusack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Cusack. Barry Cusack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Mahmoud, Ahmed Abdelaal Ahmed, et al.. (2019). Addition of Neostigmine and Atropine to Conventional Management of Postdural Puncture Headache: A Randomized Controlled Trial. Obstetric Anesthesia Digest. 39(3). 164–165. 2 indexed citations
2.
Parimon, Tanyalak, et al.. (2014). Physical activity and cognitive function in individuals over 60 years of age: a systematic review. Clinical Interventions in Aging. 9. 661–661. 201 indexed citations
5.
Jue, Sandra G., et al.. (2004). Blood Pressure Control and Factors Predicting Control in a Treatment‐Compliant Male Veteran Population. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(2). 179–187. 12 indexed citations
6.
Cusack, Barry, et al.. (1992). Overcoming Problems with Polypharmacy and Drug Misuse in the Elderly. Clinics in Geriatric Medicine. 8(1). 143–158. 117 indexed citations
7.
Cusack, Barry, K O'Malley, J. N. Lavan, Jacques Noël, & John G. Kelly. (1985). Protein binding and disposition of lignocaine in the elderly. European Journal of Clinical Pharmacology. 29(3). 323–329. 28 indexed citations
8.
Cusack, Barry, J.G. Kelly, J. N. Lavan, Jacques Noël, & K. O’Malley. (1980). Pharmacokinetics of lignocaine in the elderly [proceedings]. British Journal of Clinical Pharmacology. 9(3). 4 indexed citations
9.
Cusack, Barry, J.G. Kelly, J. N. Lavan, Jacques Noël, & K O'Malley. (1980). Theophylline kinetics in relation to age: the importance of smoking.. British Journal of Clinical Pharmacology. 10(2). 109–114. 58 indexed citations
10.
Cusack, Barry, J.G. Kelly, J. N. Lavan, Jacques Noël, & K O'Malley. (1979). The effect of age and smoking on theophylline kinetics [proceedings]. British Journal of Clinical Pharmacology. 8(4). 384P–385P. 1 indexed citations
11.
Cusack, Barry, John G. Kelly, K O'Malley, et al.. (1979). Digoxin in the elderly: Pharmacokinetic consequences of old age. Clinical Pharmacology & Therapeutics. 25(6). 772–776. 112 indexed citations
12.
Cusack, Barry, J� Horgan, J.G. Kelly, et al.. (1978). Pharmacokinetics of digoxin in the elderly [proceedings]. British Journal of Clinical Pharmacology. 6(5). 439–439. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026